Access to Medicine, Index 2014
•
0 likes•359 views
Empresas farmacéuticas líderes en el acceso a la medicina. GSK encabeza la lista por cuarto año consecutivo. Le sigue Novo Nordisk y Johnson&Jonhson
Report
Share
Report
Share
Download to read offline
Recommended
Dr. Peter B. Bach: "What Soaring Drug Prices Mean for Patients," 9.3.15
Dr. Peter B. Bach's presentation from "What Soaring Drug Prices Mean for Patients," 9.3.15
http://www.reportingonhealth.org/content/what-soaring-drug-prices-mean-patients
Vaccine delivery and affordability are major bottlenecks
Hilleman Laboratories has entered collaborations with international organizations like Imperial College London to work on low-cost vaccine manufacturing in several developing countries. In India specifically, Hilleman has signed an agreement with NICED to further develop and commercialize Shigella vaccines and other enteric vaccines. They are also exploring a vaccine for toxic E. Coli strains. However, vaccine R&D is capital intensive and delivery challenges are a major bottleneck in India, as the delivery infrastructure is saturated. To address this, Hilleman is investigating oral vaccines and single dose options to improve delivery and affordability.
Weekly Health Care News (2016-04-03)
Weekly News Wrap-Uup on Health Care Industry (Europe, North America, Asia/Pacific) showing the latest development of most striking fundamental economic and financial news
Innovation solution
The document discusses innovation and provides information from a workshop on innovation solutions. It defines key terms like innovation and describes the innovation process. It also lists the top 10 most innovative companies in 2014 based on sales growth and return on investment. The workshop covered topics like the history of engineering and computer systems, computer aided design, 3D simulation software, and was hosted by Dassault Systemes.
Innovation solutionp2
This document provides an overview of an innovation solutions workshop seminar hosted by Dassault Systemes, Solid Works, Universidad de Manizales, and TorrealCielo Think Tank. It includes sections on the meaning of innovation, the global innovation index, the most innovative companies of 2014 according to sales growth and returns, the innovation process from inception to conception, the etymology of engineering and systems, the history and description of computer systems and engineering, engineering drawings, computer aided design, 3D simulation software from Dassault Systemes, the 3DS Academy learning materials and software, and real case studies and workshops on 3D design from sketch to full design.
4. Things just keep getting better
The document summarizes research showing that occupational exposures to hazardous substances have generally decreased over time through improvements in manufacturing processes, controls, and safety practices. It analyzes trends in exposure levels for various aerosols, gases, vapors, and fibers that have declined an average of 5-15% annually. However, there are some exceptions, such as exposures to diesel exhaust in underground mines and benzene levels in some areas of China that have not followed the overall downward trend. A variety of economic, regulatory, and cultural factors are believed to influence the implementation of controls that drive improved exposure conditions over time.
Envisia Therapeutics
This document summarizes corporate milestones and pipeline for Envisia Therapeutics, a company developing ophthalmic drug delivery systems. Key points include:
- The company was formed in 2013 and has raised $25 million in funding.
- They are developing long-acting biodegradable formulations of travoprost (ENV515) for glaucoma and difluprednate (ENV905) for post-cataract inflammation. Clinical trials are underway.
- Their PRINT technology platform can produce particles from 100nm to 1000um and is being used to develop extended release formulations of small molecules and biologics for front and back of the eye diseases.
The pharmaceutical business FINAL DRAFT
The document discusses the high costs Americans pay for patented drugs compared to other countries, with Americans paying 58% more than Switzerland and up to 118% more than Italy. It notes that regulations, limited competition, a lack of innovation, brick and mortar pharmacies, and an inefficient distribution system contribute to high drug prices. It also includes a quote that a drug one cannot afford is neither safe nor effective for the consumer.
Recommended
Dr. Peter B. Bach: "What Soaring Drug Prices Mean for Patients," 9.3.15
Dr. Peter B. Bach's presentation from "What Soaring Drug Prices Mean for Patients," 9.3.15
http://www.reportingonhealth.org/content/what-soaring-drug-prices-mean-patients
Vaccine delivery and affordability are major bottlenecks
Hilleman Laboratories has entered collaborations with international organizations like Imperial College London to work on low-cost vaccine manufacturing in several developing countries. In India specifically, Hilleman has signed an agreement with NICED to further develop and commercialize Shigella vaccines and other enteric vaccines. They are also exploring a vaccine for toxic E. Coli strains. However, vaccine R&D is capital intensive and delivery challenges are a major bottleneck in India, as the delivery infrastructure is saturated. To address this, Hilleman is investigating oral vaccines and single dose options to improve delivery and affordability.
Weekly Health Care News (2016-04-03)
Weekly News Wrap-Uup on Health Care Industry (Europe, North America, Asia/Pacific) showing the latest development of most striking fundamental economic and financial news
Innovation solution
The document discusses innovation and provides information from a workshop on innovation solutions. It defines key terms like innovation and describes the innovation process. It also lists the top 10 most innovative companies in 2014 based on sales growth and return on investment. The workshop covered topics like the history of engineering and computer systems, computer aided design, 3D simulation software, and was hosted by Dassault Systemes.
Innovation solutionp2
This document provides an overview of an innovation solutions workshop seminar hosted by Dassault Systemes, Solid Works, Universidad de Manizales, and TorrealCielo Think Tank. It includes sections on the meaning of innovation, the global innovation index, the most innovative companies of 2014 according to sales growth and returns, the innovation process from inception to conception, the etymology of engineering and systems, the history and description of computer systems and engineering, engineering drawings, computer aided design, 3D simulation software from Dassault Systemes, the 3DS Academy learning materials and software, and real case studies and workshops on 3D design from sketch to full design.
4. Things just keep getting better
The document summarizes research showing that occupational exposures to hazardous substances have generally decreased over time through improvements in manufacturing processes, controls, and safety practices. It analyzes trends in exposure levels for various aerosols, gases, vapors, and fibers that have declined an average of 5-15% annually. However, there are some exceptions, such as exposures to diesel exhaust in underground mines and benzene levels in some areas of China that have not followed the overall downward trend. A variety of economic, regulatory, and cultural factors are believed to influence the implementation of controls that drive improved exposure conditions over time.
Envisia Therapeutics
This document summarizes corporate milestones and pipeline for Envisia Therapeutics, a company developing ophthalmic drug delivery systems. Key points include:
- The company was formed in 2013 and has raised $25 million in funding.
- They are developing long-acting biodegradable formulations of travoprost (ENV515) for glaucoma and difluprednate (ENV905) for post-cataract inflammation. Clinical trials are underway.
- Their PRINT technology platform can produce particles from 100nm to 1000um and is being used to develop extended release formulations of small molecules and biologics for front and back of the eye diseases.
The pharmaceutical business FINAL DRAFT
The document discusses the high costs Americans pay for patented drugs compared to other countries, with Americans paying 58% more than Switzerland and up to 118% more than Italy. It notes that regulations, limited competition, a lack of innovation, brick and mortar pharmacies, and an inefficient distribution system contribute to high drug prices. It also includes a quote that a drug one cannot afford is neither safe nor effective for the consumer.
Pfizer Tops, Novartis and Johnson & Johnson follows on Social media this Febr...
Key Findings:
1) Pfizer is the most social pharmaceutical company in February.
2) Pfizer is the most mentioned brand on Social media followed by Novartis
3) Bayer and Johnson & Johnson combined constitutes 70% of the Industry’s Facebook fan base
4) With the Twitter engagement score of 94, Pfizer bagged the first rank among the top10.
5) With an SSI of 81, Novartisis the biggest gainer during February 2014, it moved from 5th rank in January to 2nd rank in February 2014.
6) Eli Lilly & Co tweeted the most on Twitter.
7) Bayer & Novo Nordisk has highly active fan base and at the same time a very high fan base.
A total of 20 global companies were considered in the analysis.
Sales & PLC of Gleevec
This document provides sales data and a product lifecycle (PLC) graph for Gleevec, a drug produced by Novartis to treat various cancers. It summarizes that Gleevec was launched in 2001, is patented until 2017, has generated over $4.5 billion in revenue, and quarterly sales from 2011-2014 that ranged from $347-498 million. A PLC graph projects Gleevec sales to remain steady until the loss of patent protection in 2017.
Pharma marketing
The document discusses marketing management in the pharmaceutical industry. It provides insights into the roles and responsibilities of marketers and brand managers in the industry. It discusses key aspects of marketing management including market research, forecasting, business modeling, communication strategies, training sales teams, monitoring results, and working with third party agencies. It also provides data on the Pakistani pharmaceutical market size and growth of top companies. Global prevalence data and projections for hypertension are presented to illustrate how marketers select markets to serve.
Novartis - Strategy Memo
The document discusses Novartis, a Swiss pharmaceutical company. It provides background on Novartis, including that it was created through a 1996 merger. It then discusses Novartis' case regarding an Indian patent, with timelines of key events from 1997 to 2009. Finally, it summarizes that Novartis spent very little (0.03%) of its Indian revenue on research and development in India, contradicting claims that restricting patents would reduce innovation.
Pharma Magazine (Issue - 29)
The document discusses future prospects and challenges for biotherapeutics. It begins by defining biotherapeutics as products produced using living cells or organisms, such as recombinant hormones, vaccines, monoclonal antibodies, growth factors, and gene and cell therapies. It then contrasts biotherapeutics, biosimilars, and generics. The document outlines the complex manufacturing process for biotherapeutics and challenges in characterizing their large, complex structures. It concludes by discussing switching and interchangeability studies required to demonstrate a biosimilar is as safe and effective as the reference biologic.
PediaSure Competitor Analysis Report
This document provides an overview of Abbott Laboratories and the infant and baby nutrition market. Abbott Laboratories generates revenue from nutritional products, diagnostic products, established pharmaceuticals, and medical devices. Their nutritional segment includes products for infants, children, and adults. The global baby food market was estimated at $53 billion in 2015 and is projected to reach $76 billion by 2018. Leading players include Abbott, Nestle, and Mead Johnson. The Pakistan baby nutrition market was worth $17 billion in 2017 and is estimated to reach $26 billion by 2022, growing at 11% annually.
Opportunities of BDS in Pharmaceutical Industries.pptx
India is the second-largest pharmaceutical market in Asia. ... A BDS graduate can have various job roles available in this sector: Principal Investigator, Co-investigator, Medical Advisor, Drug Developer, Regulatory Affairs Manager or even a Clinical Research Physician.
Career opportunities in the clinical research field are many and varied, with employment settings ranging from pharmaceutical and biotechnology, to medical device companies, contract research organizations, hospitals, educational institutions, independent contractors and more.
Many professionals with a strong science or healthcare related background — such as nurses, pharmacists, medical technologists, physicians and more — are well-positioned to join the clinical research field. Here are 10 career paths in the field.
Pfizer strategy for internationalization
This document provides an overview of Pfizer, a global pharmaceutical company. It discusses Pfizer's vision, mission, strategic moves, organizational structure, and key financial metrics. Pfizer discovers, develops, and markets prescription medicines for humans and animals. It has grown through acquisitions and partnerships, and restructured in 2014 to focus on innovative pharmaceuticals, vaccines, and consumer healthcare. Pfizer faces challenges from patent expirations and increasing costs of drug development.
Johnson & Johnson Top Pharma Company in Social Media, GSK and Pfizer follow
Key Findings:
Johnson & Johnson is the most social Pharma company in the world followed by Glaxo Smith Kline and Pfizer.
Johnson & Johnson is the most mentioned brand on social media.
Bayer has the most active and the highest fan base on Facebook. As a result Bayer is ranked no. 1 on Facebook among all competitors.
Pfizer scored the highest on Twitter.
First word pharma outlook q1 2013
The document summarizes key findings from FirstWord Pharma's analysis of the top 50 pharmaceutical products expected to drive sales growth between 2012-2017. Some of the main points include:
- These 50 products are forecast to contribute $80 billion in additional revenue over the period. The top 15 products will account for over 50% of this growth.
- Gilead's sofosbuvir, Roche's Perjeta, Merck's Januvia, Biogen's Tecfidera and AbbVie's Humira are each expected to contribute over $3 billion individually to industry growth.
- Both large pharmaceutical companies and leading biotechs will benefit, though many "biotech" drugs are now
Competitive Analysis of Abbott Laboratories
Abbott Laboratories (Pakistan) is a pharmaceutical company founded in 1888 that has been operating in Pakistan since 1948. It has over 1,500 employees and manufacturing facilities in Karachi. The company produces pharmaceuticals, nutritional products, diagnostics, and medical devices. Abbott's main competitors in Pakistan include GSK, Searle Pakistan, Sanofi Aventis, Ferozsons Labs, and Pfizer. An analysis of Abbott's strengths, weaknesses, opportunities, and threats was conducted, as well as financial analysis showing steady growth from 2012-2017. Recommendations included focusing on products with fewer side effects, reducing employee turnover, engaging with the government, and adopting new technologies.
Ranvver sharma ppt
Ranveer Sharma from the Department of Biotech at Bcet Gurdaspur presented on Panacea Biotec. Panacea Biotec is an Indian healthcare company focused on pharmaceuticals, biopharmaceuticals, vaccines and natural products. It has a global footprint in over 30 countries. Key highlights included its #4 ranking in vaccines in India, state-of-the-art manufacturing facilities approved by US FDA and WHO, and strategic collaborations with companies like Serum Institute of India and Apotex. Recent updates discussed a collaboration with Serum Institute on a hexavalent vaccine and a settlement agreement with Celgene regarding patents on Panacea's generic version of Abraxane.
Summer Internship Report
Here are some key facts and figures about the global pharmaceutical industry:
- The global pharmaceutical market was estimated to be worth around $1.2 trillion in 2020. It is projected to reach $1.6 trillion by 2026.
- The top 10 global pharmaceutical companies by revenue in 2020 were Johnson & Johnson, Pfizer, Roche, Sanofi, Novartis, Merck & Co., AbbVie, GSK, Amgen, and Gilead Sciences.
- The top three pharmaceutical markets by sales in 2020 were the US at $360 billion, China at $145 billion, and Japan at $102 billion.
- The US accounted for around 40% of global pharmaceutical spending in 2020, despite
Ranbaxycompanyprofile
Ranbaxy is India's largest pharmaceutical company with a global footprint in 43 countries. It has a diverse product portfolio and strong R&D capabilities. In 2011, Ranbaxy recorded global sales of $2.1 billion, with emerging and developed markets each contributing around 47% and 46% respectively. Ranbaxy aims to grow organically and inorganically, focusing on high-growth areas like biologics and injectables. It also has a hybrid business model through its alliance with Daiichi Sankyo to create an innovator and generic powerhouse. Ranbaxy emphasizes R&D as a strategic priority and has over 1,200 personnel dedicated to research.
Roche Diagnostics
Roche Diagnostics conducted customer satisfaction surveys to better understand customer needs and identify areas for improvement. They established new customer service initiatives like a toll-free hotline and dedicated customer support teams. Linking customer satisfaction to profits allows Roche to focus on enhancing the customer experience which drives customer loyalty and future sales.
Roche_Genentech_Company_Presentation_2022.pdf
Roche and Genentech are leading healthcare companies dedicated to innovation in a sustainable way. Roche was founded in 1896 in Basel and still has majority family ownership. It has over 100,000 employees worldwide and sales of 62.8 billion CHF in 2021. Roche invests heavily in R&D and healthcare and was among the top companies in the Dow Jones Sustainability Index for 13 consecutive years. Genentech was the first publicly-owned biotech company. Roche has a unique innovation model with independent research centers worldwide and global product development, manufacturing, and commercialization. It manages over 250 partnerships and is optimally positioned as the leader in personalized healthcare through diagnostics, therapies, and decision support. Roche Partnering has
10 Best Companies in Nutraceutical Market 2023V3 2.pdf
In the latest edition of Insights care, we bring to your reference the 10 Best Companies in Nutraceutical Market 2023 that are bringing the natural touch to the Healthcare Industry with their safe and durable neutraceutical products.
The pharma outlook 2015
This document summarizes information about the top 15 pharmaceutical companies in the world in 2015. It provides sales figures and rankings for the top 5 selling drugs worldwide from 2014. It also discusses how the "patent cliff" has affected drug makers as major drugs lose patent protection. Additionally, it outlines key factors for the US pharmaceutical industry's success and discusses the growing pharmaceutical industry and market in India.
Public Device & Biopharma Ophthalmology Company Showcase - pSivida
Public Device & Biopharma Ophthalmology Company Showcase - pSivida at OIS@AAO 2016.
Presenter:
Nancy Lurker, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Biosimilar Dug Development
QPS is a contract research organization that specializes in developing close relationships with clients based on trust and mutual respect. They offer flexible and nimble clinical work to improve outsourced work quality and reduce oversight needs. Their biosimilar drug development expertise can help clients advance their biosimilar portfolios in a timely manner for the benefit of patients worldwide.
Pharma Market nº 66
Aquí hay algunas estrategias clave que se podrían poner en marcha desde la economía de la salud para ayudar a los gestores a medir resultados en salud:
1. Desarrollar medidas eficaces de recopilación de datos que permitan medir resultados relevantes en salud como supervivencia, calidad de vida, satisfacción del paciente, etc. Esto requiere sistemas de información sanitaria sólidos.
2. Publicar los resultados obtenidos para fomentar la transparencia y permitir su análisis e implementación en la toma de decisiones.
Pharma Market nº65
El documento discute la importancia de la colaboración entre la industria farmacéutica y las administraciones para impulsar la innovación y la sostenibilidad del sistema de salud español. También destaca la necesidad de optimizar los recursos disponibles y mejorar la formación de los profesionales sanitarios y los pacientes, especialmente desde edades tempranas, para fomentar hábitos de vida saludables. Las administraciones y empresas privadas deben colaborar en este objetivo a través del apoyo institucional y el patrocinio
More Related Content
Similar to Access to Medicine, Index 2014
Pfizer Tops, Novartis and Johnson & Johnson follows on Social media this Febr...
Key Findings:
1) Pfizer is the most social pharmaceutical company in February.
2) Pfizer is the most mentioned brand on Social media followed by Novartis
3) Bayer and Johnson & Johnson combined constitutes 70% of the Industry’s Facebook fan base
4) With the Twitter engagement score of 94, Pfizer bagged the first rank among the top10.
5) With an SSI of 81, Novartisis the biggest gainer during February 2014, it moved from 5th rank in January to 2nd rank in February 2014.
6) Eli Lilly & Co tweeted the most on Twitter.
7) Bayer & Novo Nordisk has highly active fan base and at the same time a very high fan base.
A total of 20 global companies were considered in the analysis.
Sales & PLC of Gleevec
This document provides sales data and a product lifecycle (PLC) graph for Gleevec, a drug produced by Novartis to treat various cancers. It summarizes that Gleevec was launched in 2001, is patented until 2017, has generated over $4.5 billion in revenue, and quarterly sales from 2011-2014 that ranged from $347-498 million. A PLC graph projects Gleevec sales to remain steady until the loss of patent protection in 2017.
Pharma marketing
The document discusses marketing management in the pharmaceutical industry. It provides insights into the roles and responsibilities of marketers and brand managers in the industry. It discusses key aspects of marketing management including market research, forecasting, business modeling, communication strategies, training sales teams, monitoring results, and working with third party agencies. It also provides data on the Pakistani pharmaceutical market size and growth of top companies. Global prevalence data and projections for hypertension are presented to illustrate how marketers select markets to serve.
Novartis - Strategy Memo
The document discusses Novartis, a Swiss pharmaceutical company. It provides background on Novartis, including that it was created through a 1996 merger. It then discusses Novartis' case regarding an Indian patent, with timelines of key events from 1997 to 2009. Finally, it summarizes that Novartis spent very little (0.03%) of its Indian revenue on research and development in India, contradicting claims that restricting patents would reduce innovation.
Pharma Magazine (Issue - 29)
The document discusses future prospects and challenges for biotherapeutics. It begins by defining biotherapeutics as products produced using living cells or organisms, such as recombinant hormones, vaccines, monoclonal antibodies, growth factors, and gene and cell therapies. It then contrasts biotherapeutics, biosimilars, and generics. The document outlines the complex manufacturing process for biotherapeutics and challenges in characterizing their large, complex structures. It concludes by discussing switching and interchangeability studies required to demonstrate a biosimilar is as safe and effective as the reference biologic.
PediaSure Competitor Analysis Report
This document provides an overview of Abbott Laboratories and the infant and baby nutrition market. Abbott Laboratories generates revenue from nutritional products, diagnostic products, established pharmaceuticals, and medical devices. Their nutritional segment includes products for infants, children, and adults. The global baby food market was estimated at $53 billion in 2015 and is projected to reach $76 billion by 2018. Leading players include Abbott, Nestle, and Mead Johnson. The Pakistan baby nutrition market was worth $17 billion in 2017 and is estimated to reach $26 billion by 2022, growing at 11% annually.
Opportunities of BDS in Pharmaceutical Industries.pptx
India is the second-largest pharmaceutical market in Asia. ... A BDS graduate can have various job roles available in this sector: Principal Investigator, Co-investigator, Medical Advisor, Drug Developer, Regulatory Affairs Manager or even a Clinical Research Physician.
Career opportunities in the clinical research field are many and varied, with employment settings ranging from pharmaceutical and biotechnology, to medical device companies, contract research organizations, hospitals, educational institutions, independent contractors and more.
Many professionals with a strong science or healthcare related background — such as nurses, pharmacists, medical technologists, physicians and more — are well-positioned to join the clinical research field. Here are 10 career paths in the field.
Pfizer strategy for internationalization
This document provides an overview of Pfizer, a global pharmaceutical company. It discusses Pfizer's vision, mission, strategic moves, organizational structure, and key financial metrics. Pfizer discovers, develops, and markets prescription medicines for humans and animals. It has grown through acquisitions and partnerships, and restructured in 2014 to focus on innovative pharmaceuticals, vaccines, and consumer healthcare. Pfizer faces challenges from patent expirations and increasing costs of drug development.
Johnson & Johnson Top Pharma Company in Social Media, GSK and Pfizer follow
Key Findings:
Johnson & Johnson is the most social Pharma company in the world followed by Glaxo Smith Kline and Pfizer.
Johnson & Johnson is the most mentioned brand on social media.
Bayer has the most active and the highest fan base on Facebook. As a result Bayer is ranked no. 1 on Facebook among all competitors.
Pfizer scored the highest on Twitter.
First word pharma outlook q1 2013
The document summarizes key findings from FirstWord Pharma's analysis of the top 50 pharmaceutical products expected to drive sales growth between 2012-2017. Some of the main points include:
- These 50 products are forecast to contribute $80 billion in additional revenue over the period. The top 15 products will account for over 50% of this growth.
- Gilead's sofosbuvir, Roche's Perjeta, Merck's Januvia, Biogen's Tecfidera and AbbVie's Humira are each expected to contribute over $3 billion individually to industry growth.
- Both large pharmaceutical companies and leading biotechs will benefit, though many "biotech" drugs are now
Competitive Analysis of Abbott Laboratories
Abbott Laboratories (Pakistan) is a pharmaceutical company founded in 1888 that has been operating in Pakistan since 1948. It has over 1,500 employees and manufacturing facilities in Karachi. The company produces pharmaceuticals, nutritional products, diagnostics, and medical devices. Abbott's main competitors in Pakistan include GSK, Searle Pakistan, Sanofi Aventis, Ferozsons Labs, and Pfizer. An analysis of Abbott's strengths, weaknesses, opportunities, and threats was conducted, as well as financial analysis showing steady growth from 2012-2017. Recommendations included focusing on products with fewer side effects, reducing employee turnover, engaging with the government, and adopting new technologies.
Ranvver sharma ppt
Ranveer Sharma from the Department of Biotech at Bcet Gurdaspur presented on Panacea Biotec. Panacea Biotec is an Indian healthcare company focused on pharmaceuticals, biopharmaceuticals, vaccines and natural products. It has a global footprint in over 30 countries. Key highlights included its #4 ranking in vaccines in India, state-of-the-art manufacturing facilities approved by US FDA and WHO, and strategic collaborations with companies like Serum Institute of India and Apotex. Recent updates discussed a collaboration with Serum Institute on a hexavalent vaccine and a settlement agreement with Celgene regarding patents on Panacea's generic version of Abraxane.
Summer Internship Report
Here are some key facts and figures about the global pharmaceutical industry:
- The global pharmaceutical market was estimated to be worth around $1.2 trillion in 2020. It is projected to reach $1.6 trillion by 2026.
- The top 10 global pharmaceutical companies by revenue in 2020 were Johnson & Johnson, Pfizer, Roche, Sanofi, Novartis, Merck & Co., AbbVie, GSK, Amgen, and Gilead Sciences.
- The top three pharmaceutical markets by sales in 2020 were the US at $360 billion, China at $145 billion, and Japan at $102 billion.
- The US accounted for around 40% of global pharmaceutical spending in 2020, despite
Ranbaxycompanyprofile
Ranbaxy is India's largest pharmaceutical company with a global footprint in 43 countries. It has a diverse product portfolio and strong R&D capabilities. In 2011, Ranbaxy recorded global sales of $2.1 billion, with emerging and developed markets each contributing around 47% and 46% respectively. Ranbaxy aims to grow organically and inorganically, focusing on high-growth areas like biologics and injectables. It also has a hybrid business model through its alliance with Daiichi Sankyo to create an innovator and generic powerhouse. Ranbaxy emphasizes R&D as a strategic priority and has over 1,200 personnel dedicated to research.
Roche Diagnostics
Roche Diagnostics conducted customer satisfaction surveys to better understand customer needs and identify areas for improvement. They established new customer service initiatives like a toll-free hotline and dedicated customer support teams. Linking customer satisfaction to profits allows Roche to focus on enhancing the customer experience which drives customer loyalty and future sales.
Roche_Genentech_Company_Presentation_2022.pdf
Roche and Genentech are leading healthcare companies dedicated to innovation in a sustainable way. Roche was founded in 1896 in Basel and still has majority family ownership. It has over 100,000 employees worldwide and sales of 62.8 billion CHF in 2021. Roche invests heavily in R&D and healthcare and was among the top companies in the Dow Jones Sustainability Index for 13 consecutive years. Genentech was the first publicly-owned biotech company. Roche has a unique innovation model with independent research centers worldwide and global product development, manufacturing, and commercialization. It manages over 250 partnerships and is optimally positioned as the leader in personalized healthcare through diagnostics, therapies, and decision support. Roche Partnering has
10 Best Companies in Nutraceutical Market 2023V3 2.pdf
In the latest edition of Insights care, we bring to your reference the 10 Best Companies in Nutraceutical Market 2023 that are bringing the natural touch to the Healthcare Industry with their safe and durable neutraceutical products.
The pharma outlook 2015
This document summarizes information about the top 15 pharmaceutical companies in the world in 2015. It provides sales figures and rankings for the top 5 selling drugs worldwide from 2014. It also discusses how the "patent cliff" has affected drug makers as major drugs lose patent protection. Additionally, it outlines key factors for the US pharmaceutical industry's success and discusses the growing pharmaceutical industry and market in India.
Public Device & Biopharma Ophthalmology Company Showcase - pSivida
Public Device & Biopharma Ophthalmology Company Showcase - pSivida at OIS@AAO 2016.
Presenter:
Nancy Lurker, President & CEO
Powered by:
Healthegy
For more ophthalmology innovation
Visit us at www.ois.net
Biosimilar Dug Development
QPS is a contract research organization that specializes in developing close relationships with clients based on trust and mutual respect. They offer flexible and nimble clinical work to improve outsourced work quality and reduce oversight needs. Their biosimilar drug development expertise can help clients advance their biosimilar portfolios in a timely manner for the benefit of patients worldwide.
Similar to Access to Medicine, Index 2014 (20)
Pfizer Tops, Novartis and Johnson & Johnson follows on Social media this Febr...
Pfizer Tops, Novartis and Johnson & Johnson follows on Social media this Febr...
Opportunities of BDS in Pharmaceutical Industries.pptx
Opportunities of BDS in Pharmaceutical Industries.pptx
Johnson & Johnson Top Pharma Company in Social Media, GSK and Pfizer follow
Johnson & Johnson Top Pharma Company in Social Media, GSK and Pfizer follow
10 Best Companies in Nutraceutical Market 2023V3 2.pdf
10 Best Companies in Nutraceutical Market 2023V3 2.pdf
Public Device & Biopharma Ophthalmology Company Showcase - pSivida
Public Device & Biopharma Ophthalmology Company Showcase - pSivida
More from Pharma Market
Pharma Market nº 66
Aquí hay algunas estrategias clave que se podrían poner en marcha desde la economía de la salud para ayudar a los gestores a medir resultados en salud:
1. Desarrollar medidas eficaces de recopilación de datos que permitan medir resultados relevantes en salud como supervivencia, calidad de vida, satisfacción del paciente, etc. Esto requiere sistemas de información sanitaria sólidos.
2. Publicar los resultados obtenidos para fomentar la transparencia y permitir su análisis e implementación en la toma de decisiones.
Pharma Market nº65
El documento discute la importancia de la colaboración entre la industria farmacéutica y las administraciones para impulsar la innovación y la sostenibilidad del sistema de salud español. También destaca la necesidad de optimizar los recursos disponibles y mejorar la formación de los profesionales sanitarios y los pacientes, especialmente desde edades tempranas, para fomentar hábitos de vida saludables. Las administraciones y empresas privadas deben colaborar en este objetivo a través del apoyo institucional y el patrocinio
Pharma Market nº64, Mayo 2015
El documento habla sobre el papel de los profesionales de desarrollo de negocio en la industria farmacéutica y la asociación PLGS que los representa. PLGS se ha consolidado como el foro y punto de encuentro de estos profesionales en España. El rol de los profesionales de desarrollo de negocio ha evolucionado para requerir aptitudes multidisciplinarias y entender procesos clínicos más allá de sólo los fármacos. PLGS ofrece formación especializada y eventos de networking para ayudar a los
Pharma Market nº63, Abril 2015
La Revista Digital con Información de Valor para la Toma de Decisiones Estratégicas de la Industria Farmacéutica
Pharma Marlet nº62
La revista digital con información de valor para la toma de decisiones estratégicas de la industria farmacéutica
Pharma market nº61, Febrero 2015
La revista digital con información de valor para la toma de decisiones estratégicas en la Industria Farmacéutica
Pharma Market nº 60, Enero 2015
La revista digital con información de valor para la toma de decisiones estratégicas de la Industria Farmacéutica
Big data, la medicina del futuro
El Big Data ya supone una revolución para el sector salud. Permite una medicina personalizada, predictiva y participativa mediante el análisis de los grandes volúmenes de datos clínicos y de salud que se generan. Esto mejorará el diagnóstico, permitirá la detección temprana de enfermedades y favorecerá el autocuidado.
Pharma market nº 59, Diciembre 2014
El documento describe algunos de los principales retos que enfrentan el Sistema Nacional de Salud español, la industria farmacéutica y los pacientes en 2015. Estos incluyen la necesidad de que los pacientes sean más responsables en el manejo de sus enfermedades, que la industria demuestre valor añadido más allá de la innovación científica, y que haya una mayor colaboración entre los gestores, profesionales y la industria centrada en el paciente. También señala la importancia de los equipos multidiscipl
Pharma Market 58
El documento habla sobre la innovación en el sector de la salud y la importancia de la prevención y el autocuidado de la salud. Argumenta que prevenir una enfermedad siempre es más barato que tratarla, por lo que el autocuidado de la salud debería formar parte integral de los sistemas sanitarios. También destaca la necesidad de evaluar la innovación de forma integral, incluyendo los costes y beneficios directos e indirectos para los pacientes.
Pharma Market 57
El documento habla sobre los retos de la industria farmacéutica de innovar y crecer mediante la I+D, de forma compatible con el control del déficit público. También menciona los esfuerzos para mantener la calidad del sistema nacional de salud, incluyendo herramientas para la estratificación de pacientes y la atención domiciliaria. Por último, señala que las enfermedades raras, aunque representan un pequeño porcentaje del gasto farmacéutico actualmente, plantean nuevos retos en términos de
Pharma Market 56
El documento presenta una entrevista a dos periodistas especializados en salud, Noemí Navas de Cinco Días y Alberto Vigario de El Economista. Ambos creen que la calidad de la salud en España podría verse amenazada en los próximos años debido a los recortes en gasto sanitario. Ven importante que la industria farmacéutica se esfuerce en mantener la confianza de los ciudadanos en los medicamentos y vacunas mediante una información veraz, fiable y de calidad.
Pharma Market 55
El documento presenta los resultados de un estudio sobre las necesidades de los pacientes crónicos en España. El estudio encontró que los pacientes crónicos experimentan desorientación en la atención especializada, reciben información fragmentada y tienen dificultades para entender su proceso de atención. También se identificaron barreras como la falta de tiempo durante las consultas y materiales informativos demasiado complejos. El estudio concluye que es necesario mejorar la comunicación con los pacientes y promover su autocuidado y competencias en salud.
Pharma Market 54
El documento habla sobre el tercer Plan de Pago a Proveedores del gobierno español. El 61,4% del dinero del primer tramo (3,881.67 millones de euros) irá a pagar facturas atrasadas del sector sanitario. Este plan permitirá pagar 167,000 facturas de 29,000 proveedores de 9 comunidades autónomas. En total, el plan pagará 11,600 millones de euros en facturas atrasadas, con el 61,4% destinado a proveedores sanitarios. El plan ayudará a poner al día el pago de fact
Pharma Market 53
Este documento resume varios temas relacionados con la industria farmacéutica en España. En primer lugar, se suspende provisionalmente la adjudicación del acuerdo para Alternativas Terapéuticas Equivalentes debido a recursos presentados. Además, el TSJM suspende la resolución para externalizar la gestión de seis hospitales públicos de Madrid. Por último, la Comunidad de Madrid destinará casi 10 millones de euros a la adquisición de fármacos para los hospitales Ramón y Cajal y La Paz.
Pharma Market 52
Este documento discute los desafíos actuales que enfrenta la industria farmacéutica en España, incluyendo la reducción del gasto público en medicamentos y la necesidad de generar valor e innovación para garantizar la sostenibilidad del sistema de salud. También destaca la importancia de la adherencia terapéutica y el enfoque en el paciente a través del desarrollo de medicamentos basados en el valor y la evidencia de acceso. Finalmente, enfatiza la necesidad de una estrategia multicanal para comunicarse mejor con los clientes y aport
Pharma Market 51
Este documento resume varios temas relacionados con la industria farmacéutica, incluyendo el acceso al mercado en el sector diagnóstico, la adherencia al tratamiento, el marketing social, la formación continua, y las nuevas herramientas y retos en áreas como el marketing, las relaciones humanas, las ventas y el desarrollo de negocios. También incluye entrevistas con expertos de diferentes compañías farmacéuticas.
Pharma Market 50
El documento resume las nuevas secciones y contenidos que se incorporarán a la revista Pharma Market para adaptarse a los cambios en el modelo de negocio del sector farmacéutico. Se añadirán secciones como Market Access, Marketing, Médico y MSL, Recursos Humanos, entre otras. El objetivo es generar contenido dinámico que ayude a los profesionales del sector a tomar mejores decisiones.
Pharma Market 49
Este documento presenta las opiniones de varios expertos sobre el estado de la innovación en España. Argumentan que la innovación no ha sido una prioridad en las agendas políticas del país y existe poca capacidad de innovación en las empresas y políticas públicas. Se necesita un compromiso nacional para fomentar la innovación a través de una cultura social favorable y modelos de transferencia de conocimiento entre investigación y empresas. A pesar de informes previos sobre estas cuestiones, todavía queda por aplicar recomendaciones prácticas como mejorar la colaboración entre sectores
Pharma Market 48
Este documento presenta las siguientes propuestas de la Comisión Europea:
1) Dos nuevos reglamentos sobre dispositivos médicos y productos de diagnóstico in vitro con el objetivo de lograr mayor transparencia y adaptación a avances científicos y tecnológicos.
2) Los reglamentos introducen mayores requisitos de evaluación, trazabilidad, investigación clínica y clasificación de riesgos. También crean una base de datos pública sobre dispositivos médicos.
3) Se espera que los reglamentos
More from Pharma Market (20)
Recently uploaded
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxMGM SCHOOL/COLLEGE OF NURSING
Identification and nursing management of congenital malformations Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...chandankumarsmartiso
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun Women Seeking Service
Histololgy of Female Reproductive System.pptx
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.Light House Retreats: Plant Medicine Retreat Europe
Our aim is to organise conscious gatherings and retreats for open and inquisitive minds and souls, with and without the assistance of sacred plants.
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
The Best Ayurvedic Antacid Tablets in India
Treat the symptoms of indigestion, heartburn and stomach reflux with the 10 Best Ayurvedic Antacid Tablets in India.
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Recently uploaded (20)
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
#cALL# #gIRLS# In Dehradun ꧁❤8107221448❤꧂#cALL# #gIRLS# Service In Dehradun W...
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Access to Medicine, Index 2014
- 1. Access to Medicine Index 2014 Overall Company Ranking 26 Figure 10 The Access to Medicine Index 2014 – Overall Ranking 0 1 2 3 4 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 1 6 2 7 5 8 4 3 n/a 9 15 10 12 17 16 11 14 20 19 18 3.29 3.01 2.84 2.84 2.81 2.77 2.64 2.57 2.56 2.51 2.47 2.30 2.23 2.08 1.94 1.93 1.73 1.56 1.50 1.45 GlaxoSmithKline plc Novo Nordisk A/S Johnson & Johnson Novartis AG Gilead Sciences Inc. Merck KGaA Merck & Co. Inc. Sano AbbVie Inc. Bayer AG Eisai Co. Ltd. Roche Holding AG Bristol-Myers Squibb Co. Boehringer Ingelheim GmbH AstraZeneca plc Pzer Inc. Eli Lilly Co. Astellas Pharma Inc. Daiichi Sankyo Co. Ltd. Takeda Pharmaceutical Co. Ltd. General Access to Medicine Management Public Policy Market Inuence Research Development Pricing, Manufacturing Distribution Patents Licensing Capability Advancement in Product Development Distribution Product Donations Philanthropic Activities Position Access to Medicine Index 2012 Position Access to Medicine Index 2014 A score of zero means lowest and five signifies highest indicator score among the company set.